Warning: members of the public are being contacted by people claiming to work for AXA Investment Managers UK Limited.  Find out more information and what to do by clicking here.

Longevity Economy strategy - August 2021

  • 22 September 2021 (5 min read)

Q2 earnings season showed solid results driven by strong momentum in United States

  • Equity markets continued to rise in August, supported by positive economic growth
  • The strategy behaved positively despite negative contribution from our “senior care” theme
  • Focus remains on long-term changes brought about by ageing populations

What’s happening?

Second quarter earnings wrapped up with many companies reporting better than predicted earnings, so it is no surprise that global equity markets continued to rise in August driven by strong momentum in US stocks. However, there was significant stock price volatility for the minority of companies that missed expectations.

Increased regulatory scrutiny of multiple industries in China caused volatility in exposed names. For example, many luxury goods companies experienced share price declines as Chinese authorities expressed a desire for redistribution of wealth.

The US Senate passed a budget resolution allowing the Democrat’s $3.5 trillion spending plan, which if enacted in its current form would represent a significant expansion of US government spending and comes hot on the heels of the $1 trillion infrastructure bill. US Federal Reserve (Fed) Chairman spoke at the Jackson Hole symposium, and while Jerome Powell left open the possibility that the Fed may begin tapering stimulus in 2021, a weak US jobs report in August lessened the likelihood of this occurring.

Portfolio positioning and performance

The longevity economy strategy underperformed the broader market equities (MSCI All Country World) in August driven principally by weakness in the senior care theme. Senior care exhibited weakness as home health and nursing providers reported weaker than expected second quarter business updates.

Focusing on the care needs of senior citizens is a core theme of the longevity economy. Ageing populations are expected to drive significant growth in demand for healthcare and particularly senior care services. At home care offers greater flexibility in care delivery and patients can benefit from receiving care where they feel most comfortable. During the initial phase of the COVID-19 pandemic, there was significantly increased demand for care away from hospitals and traditional primary care centres. However, as we exit the worst of the pandemic, there is great uncertainty over where demand will stabilise in the short term, as a result we are seeing significant volatility in share prices of exposed firms such as Amedisys.

Ageing populations are not just a developed market trend. There are rapidly growing older populations in many Asia-Pacific countries, which creates opportunities for companies that recognise and seek exposure to this trend. UK-listed insurer, Prudential stands out as a company that has pivoted its business to gain exposure to this trend. In August the company began the demerger of its US savings and investment business, Jackson Financial, which once completed will leave Prudential to focus principally on the faster growing Asia market. The recent rally in shares suggests investors are starting to anticipate the improved growth profile for the company.


Global markets continued to rally in August, setting fresh all-time highs driven by positive economic growth in multiple regions. However, at times economic data has been contradictory, for example the US Federal Reserve has left open the possibility of tapering its stimulus program by year end suggesting confidence in US growth, but the August jobs report was weaker than expected, which could present problems for policymakers. Overall, we remain cautiously optimistic because data from the UK’s recent surge coronavirus cases has shown lower hospitalisation rates that demonstrate the benefit and safety of the COVID-19 vaccines. However, caution is warranted over the recent increase in COVID-19 cases in the Southern United States due to the lower rate of vaccination in many of these states. Already some social distancing and mask-wearing requirements are being reimposed, the impact of these measures on regional economies is not clear, but could unsettle markets.

Stepping back from macroeconomic considerations, we retain the view that high quality management teams, operating businesses with a sustainable competitive advantage and with the benefit of secular tailwinds are well-placed to navigate the current disruption. Despite the headwinds many businesses faced during the pandemic, the unshakeable conclusion on the outlook for the longevity economy is that the global population continues to age and this creates opportunities for companies that are positioned to benefit from long-term changes in consumption patterns that ageing populations will bring.

No assurance can be given that the Longevity Economy Strategy will be successful. Investors can lose some or all of their capital invested. The Longevity Economy Strategy is subject to risks including: Equity; Currency; Global Investments; Emerging markets; Investments in small capitalisation universe and Investment in specific asset classes.

Read the full article
Download article (225.22 KB)

Related Articles


Global Thematics strategy - February 2023

  • by David Shaw, Mark Hargraves
  • 21 February 2023 (5 min read)

Global Thematics strategy - January 2023

  • by David Shaw, Mark Hargraves
  • 15 February 2023 (5 min read)

Global Thematics strategy - July 2022

  • by Amanda O’Toole
  • 19 August 2022 (5 min read)

    Not for retail distribution

    This document is intended exclusively for Professional, Institutional, Qualified or Wholesale Clients / Investors only, as defined by applicable local laws and regulation. Circulation must be restricted accordingly.

    Past performance is not a guide to current or future performance, and any performance or return data displayed does not take into account commissions and costs.

    This document is for informational purposes only and does not constitute investment research or financial analysis relating to transactions in financial instruments as per MIF Directive (2014/65/EU), nor does it constitute on the part of AXA Investment Managers or its affiliated companies an offer to buy or sell any investments, products or services, and should not be considered as solicitation or investment, legal or tax advice, a recommendation for an investment strategy or a personalized recommendation to buy or sell securities.

    Due to its simplification, this document is partial and opinions, estimates and forecasts herein are subjective and subject to change without notice. There is no guarantee forecasts made will come to pass. Data, figures, declarations, analysis, predictions and other information in this document is provided based on our state of knowledge at the time of creation of this document. Whilst every care is taken, no representation or warranty (including liability towards third parties), express or implied, is made as to the accuracy, reliability or completeness of the information contained herein. Reliance upon information in this material is at the sole discretion of the recipient. This material does not contain sufficient information to support an investment decision.

    Past performance is not a guide to current or future performance, and any performance or return data displayed does not take into account commissions and costs incurred when issuing or redeeming units. References to league tables and awards are not an indicator of future performance or places in league tables or awards and should not be construed as an endorsement of any AXA IM company or their products or services. Please refer to the websites of the sponsors/issuers for information regarding the criteria on which the awards/ratings are based. The value of investments, and the income from them, can fall as well as rise and investors may not get back the amount originally invested. Exchange-rate fluctuations may also affect the value of their investment. Due to this and the initial charge that is usually made, an investment is not usually suitable as a short term holding.

    The products or strategies discussed in this document may not be registered nor available in your jurisdiction. Please check the countries of registration with the asset manager, or on the web site https://www.axa-im.com/en/registration-map, where a fund registration map is available. Please note that the management company reserves the right, at any time, to no longer market the product(s) mentioned in this communication in an European Union country by notification to its authority of supervision in accordance with European passport rules. In particular units of the funds may not be offered, sold or delivered to U.S. Persons within the meaning of Regulation S of the U.S. Securities Act of 1933. The tax treatment relating to the holding, acquisition or disposal of shares or units in the fund depends on each investor’s tax status or treatment and may be subject to change. Any potential investor is strongly encouraged to seek advice from its own tax advisors.

    In the event of dissatisfaction with the products or services, you have the right to make a complaint either with the marketer or directly with the management company (more information on our complaints policy available in English here). You also have the right to take legal or extra-judicial action at any time if you reside in one of the countries of the European Union. The European online dispute resolution platform allows you to enter a complaint form (by clicking here) and informs you, depending on your jurisdiction, about your means of redress (by clicking here).

    Risk Warning

    The value of investments, and the income from them, can fall as well as rise and investors may not get back the amount originally invested. 

    Are you an IFA or other Professional Investor ?

    Are you a financial advisor, institutional, or other professional investor?

    This section is for professional investors only. You need to confirm that you have the required investment knowledge and experience to view this content. This includes understanding the risks associated with investment products, and any other required qualifications according to the rules of your jurisdiction.